Skip to main content

Why now

Why non-profit & advocacy operators in chicago are moving on AI

Why AI matters at this scale

The Alzheimer's Association, as a large non-profit with a global mission, operates at a critical scale where manual processes and traditional research methods are insufficient to address the complexity and urgency of the disease. With over 1,000 employees and a vast network of chapters, researchers, and volunteers, the organization manages massive amounts of data—from scientific research and clinical trials to caregiver support interactions and donor information. At this size band (1001-5000 employees), the association has the operational heft and resources to invest in strategic technology initiatives but must do so with the cost-consciousness of a non-profit. AI presents a transformative opportunity to leverage this scale, turning disparate data assets into accelerated insights, personalized interventions, and more efficient operations, ultimately driving faster progress toward its core mission.

Concrete AI Opportunities with ROI Framing

1. Accelerating Therapeutic Discovery: The association funds hundreds of research projects. AI models, particularly in drug repurposing and novel target identification, can analyze decades of failed and successful trial data, published literature, and real-world evidence to generate new, high-probability hypotheses. The ROI is measured in years and billions of dollars saved in the drug development pipeline, potentially bringing effective treatments to patients a decade sooner.

2. Optimizing Clinical Trial Operations: Patient recruitment is a major bottleneck. An AI-driven platform can continuously analyze electronic health records (via partnerships) and the association's own TrialMatch® registry to pre-screen and match eligible participants. This can reduce recruitment timelines by 30-50%, lowering trial costs and accelerating the pace of research the association supports, improving the return on its research investment.

3. Scaling Personalized Support: The 24/7 Helpline and care consultation services are human-intensive. An AI-powered chatbot and triage system can handle routine inquiries, symptom tracking, and resource navigation, freeing expert staff for complex cases. This scales support capacity without linearly increasing staff costs, allowing the association to serve millions more caregivers effectively, a key metric for donor impact reports.

Deployment Risks Specific to this Size Band

For an organization of this size, deployment risks are significant. Integration Complexity: Legacy systems across national offices and chapters create data silos, making it difficult to build unified AI models. Talent Acquisition: Competing with private sector salaries for AI and data science talent is a constant challenge for non-profits. Change Management: Rolling out AI tools to a large, mission-driven staff requires careful communication to ensure adoption and address fears of job displacement or dehumanization of care. Funding & Prioritization: AI projects require upfront investment with delayed, albeit high, impact. This competes with immediate programmatic needs for finite donor funds, requiring strong internal advocacy and clear pilot-stage success metrics to secure ongoing investment.

alzheimer's association® at a glance

What we know about alzheimer's association®

What they do
Where they operate
Size profile
national operator

AI opportunities

5 agent deployments worth exploring for alzheimer's association®

Predictive Biomarker Discovery

Intelligent Clinical Trial Matching

AI-Powered Caregiver Chatbot

Grant Proposal & Research Triage

Personalized Risk Communication

Frequently asked

Common questions about AI for non-profit & advocacy

Industry peers

Other non-profit & advocacy companies exploring AI

People also viewed

Other companies readers of alzheimer's association® explored

See these numbers with alzheimer's association®'s actual operating data.

Get a private analysis with quantified savings ranges, deployment timeline, and use-case prioritization specific to alzheimer's association®.